REGENXBIO Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, REGENXBIO stock has a consensus rating of "Strong Buy" and an average price target of $21.4. The average 1-year stock price forecast is 180.10% higher than the current stock price, while the lowest is $12 (+57.07%) and the highest is $42 (+449.74%).

Price Target: $21.4 (+180.10%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$12	$21.4	$19	$42
Change	+57.07%	+180.10%	+148.69%	+449.74%

Analyst Ratings

The average analyst rating for REGENXBIO stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	6	6	6	6	7	7
Buy	4	4	3	3	3	3
Hold	1	1	2	2	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Maxwell Skor Morgan Stanley	Morgan Stanley	Buy Maintains $18	Buy	Maintains	$18	+135.60%	Nov 6, 2026
Luca Issi RBC Capital	RBC Capital	Buy Maintains $19	Buy	Maintains	$19	+148.69%	Nov 6, 2026
Yi Chen H.C. Wainwright	H.C. Wainwright	Buy Reiterates $21	Buy	Reiterates	$21	+174.87%	Nov 6, 2026
Alec Stranahan Bank of America Securities	Bank of America Securities	Buy Reiterates $15 → $14	Buy	Reiterates	$15 → $14	+83.25%	Nov 6, 2026
Graig Suvannavejh Mizuho Securities	Mizuho Securities	Buy Maintains $19 → $18	Buy	Maintains	$19 → $18	+135.60%	Nov 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

159.62M

from 170.44M

-6.35%

from 170.44M

Revenue Next Year

197.93M

from 159.62M

24.01%

from 159.62M

EPS This Year

-3.58

from -3.76

EPS Next Year

-3.28

from -3.58

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	470.35M	112.72M	90.24M	83.33M	170.44M	159.62M
Revenue Growth	204.30%	-76.03%	-19.94%	-7.66%	104.54%	-6.35%
Operating Income	159.98M	-255.38M	-264.43M	-231.25M	-161.20M	-171.43M
Net Income	127.84M	-280.32M	-263.49M	-227.10M	-193.88M	-190.25M
EPS	-	-	-	-	-3.76	-3.58
Free Cash Flow	-	-	-	-	-	-146.40M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	302.7M
Avg	159.6M
Low	130.1M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	77.6%
Avg	-6.4%
Low	-23.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-3.16
Avg	-3.58
Low	-4.39

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-